荷兰心脏登记:心肌切除联合主动脉瓣置换术结局
该多中心荷兰研究评估了肥厚型心肌病合并主动脉瓣狭窄患者行室间隔心肌切除联合主动脉瓣置换术的结局,并与年龄性别匹配的荷兰一般人群生存比较。队列94例,中位年龄72岁,术后左室流出道压差从73±27mmHg降至12±12mmHg,永久起搏器植入率13%,6年生存71%低于匹配人群83%。
要点
- 心肌切除联合AVR可有效解除左室流出道梗阻。
- 永久起搏器植入率为13%,是相对常见并发症。
- 长期生存低于年龄性别匹配的一般人群。
核心结论
- 心肌切除联合AVR有效缓解左室流出道梗阻,但永久起搏器植入较常见,长期生存低于匹配人群。
研究设计与样本
- 多中心回顾性队列研究,纳入2012至2020年荷兰12家医院94例肥厚型心肌病合并主动脉瓣狭窄行心肌切除联合AVR的患者。
主要发现
- 平均静息左室流出道压差从73±27mmHg改善至术后12±12mmHg。
- 永久起搏器植入率和室间隔缺损发生率分别为13%和1%。
- 术后1年和6年未调整生存率分别为90%(95%CI 85-97)和71%(95%CI 59-84)。
- 年龄性别匹配的一般人群6年生存率为83%(95%CI 70-97)。
关键数值与推荐
- 基线室间隔厚度为21mm(IQR 19-24),指数化主动脉瓣面积为0.48±0.14cm²/m²。
临床怎么用
- 对于肥厚型心肌病合并主动脉瓣狭窄患者,心肌切除联合AVR可有效解除左室流出道梗阻,但需警惕永久起搏器植入风险并关注长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objectives of this multicentre Dutch study were to evaluate outcomes of surgical myectomy with concomitant aortic valve replacement (AVR) in patients with hypertrophic cardiomyopathy (HCM) and aortic valve stenosis and to compare patient survival against age-sex-matched survival of the general Dutch population. METHODS: All HCM patients who underwent surgical myectomy with concomitant AVR between 2012 and 2020 across 12 Dutch hospitals were analysed using data from the Netherlands Heart Registration. Operative details, pre-, and in-hospital echocardiographic data, and 30-day complication rates are described. Survival is assessed using Kaplan-Meier estimates and compared to the general Dutch population. RESULTS: This cohort (n=94) included 41 males (44%) and 53 females (56%) with a median age of 72 (interquartile-range [IQR]: 67-76) years at the time of the intervention. Additional procedures to AVR were performed concomitantly in 54% of patients. Mean resting left ventricular outflow tract (LVOT) gradient improved from 73±27mmHg to 12±12 postoperatively. At baseline, septal thickness and indexed AV-area were 21 [19-24] mm, and 0.48±0.14cm2/m2, respectively. Permanent pacemaker implantation and ventricular septal defect rates were 13% and 1%, respectively. Unadjusted survival estimated at 1, and 6 years after the surgical procedure were 90% (95%CI, 85-97), and 71% (95%CI, 59-84). Age-and sex-matched survival in the general population was 83% (95%CI, 70%-97%) at 6-years. CONCLUSIONS: Surgical myectomy with concomitant AVR effectively relieved LVOT-obstruction; however, permanent pacemaker implantation was a relatively common complication. At longer-term follow-up, these patients showed lower survival compared to the age- and sex-matched general Dutch population.
引用
- Heeringa TJP, Guglielmo M, de Zan G, et al. Outcomes in Patients Undergoing Surgical Myectomy with Concomitant Aortic Valve Replacement: Data of the Netherlands Heart Registration. Ann Thorac Surg. 2026. PMID: 42785499. doi:10.1016/j.athoracsur.2026.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。